Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients who have completed 8 weeks double-blind study (B2411263), without major protocol violations or tolerability concerns in the opinion of the investigator.
You may not be if
Clinically important abnormalities on baseline (Week 8 of the double-blind study) physical examination, or any unresolved clinically significant abnormalities on electrocardiogram (ECG), laboratory test results, or vital signs recorded before Week 8 in the previous double-blind study.
Significant risk of suicide based on clinical judgment.
Use of prohibited treatments
Clareo Health | Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
